Cardio Diagnostics Holdings, Inc. executed a reverse stock split of its common stock at a ratio of 1-for-30, effective May 12, 2025, with trading on a post-split basis starting May 13, 2025. Adjustments will be made to the company's equity awards and warrants accordingly, and no fractional shares will be issued; they will be rounded up or down.